Canopy Growth Corporation Insider Trading

CGC

Last 12 months

Insiders sold 393K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director David Angelo Lazzarato sold 21K on Sep 28, 11% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2025.

Net open-market

−393K

0 buys · 21 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

Sep 2025

Sep 22, 2025

Get an email when CGC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 28	Theresa Yanofsky Director	SoldNo plan	14,920	$0.93	14K	10%	Form 4
Sep 28	David Angelo Lazzarato Director	SoldNo plan	22,380	$0.93	21K	11%	Form 4
Sep 28	Joseph Bayern Director	SoldNo plan	3,096	$0.93	3K	2.1%	Form 4
Sep 28	M Shan Atkins Director	SoldNo plan	3,096	$0.93	3K	2.1%	Form 4
Sep 17	Thomas Carlton Stewart See Remarks	SoldNo plan	25,755	$0.93	24K	4.2%	Form 4
Aug 24	Christelle Gedeon See Remarks	SoldNo plan	13,344	$1.47	20K	1.9%	Form 4
Aug 24	Thomas Carlton Stewart See Remarks	SoldNo plan	2,231	$1.47	3K	0.4%	Form 4
Jun 26	Joseph Bayern Director	SoldNo plan	3,197	$0.92	3K	2.2%	Form 4
Jun 26	Theresa Yanofsky Director	SoldNo plan	15,054	$0.92	14K	9.3%	Form 4
Jun 26	M Shan Atkins Director	SoldNo plan	3,197	$0.92	3K	2.1%	Form 4
Jun 26	David Angelo Lazzarato Director	SoldNo plan	22,674	$0.92	21K	9.7%	Form 4
Jun 17	Thomas Carlton Stewart See Remarks	SoldNo plan	9,285	$0.97	9K	1.5%	Form 4
Jun 17	Christelle Gedeon See Remarks	SoldNo plan	58,994	$0.97	57K	7.7%	Form 4
Jun 17	Luc Mongeau Chief Executive Officer	SoldNo plan	135,231	$0.97	131K	7.3%	Form 4
Mar 31	Theresa Yanofsky Director	SoldNo plan	10,373	$0.93	10K	16%	Form 4
Mar 31	M Shan Atkins Director	SoldNo plan	2,074	$0.93	2K	4.8%	Form 4
Mar 31	Joseph Bayern Director	SoldNo plan	2,658	$0.93	2K	6.2%	Form 4
Mar 31	David Angelo Lazzarato Director	SoldNo plan	15,624	$0.93	15K	18%	Form 4
Feb 11	Luc Mongeau Chief Executive Officer	SoldNo plan	9,376	$1.06	10K	1.2%	Form 4
Dec 31, 2025	Theresa Yanofsky Director	SoldNo plan	10,434	$1.13	12K	14%	Form 4
Dec 31, 2025	David Angelo Lazzarato Director	SoldNo plan	15,715	$1.13	18K	15%	Form 4
Sep 29, 2025	David Angelo Lazzarato Director	SoldNo plan	15,677	$1.58	25K	13%	Form 4
Sep 29, 2025	M Shan Atkins Director	SoldNo plan	2,216	$1.58	4K	4.9%	Form 4
Sep 29, 2025	Theresa Yanofsky Director	SoldNo plan	10,408	$1.58	16K	12%	Form 4
Sep 29, 2025	Willy Kruh Director	SoldNo plan	10,451	$1.58	17K	14%	Form 4
Sep 22, 2025	Luc Mongeau Chief Executive Officer	Bought	27,469	$1.82	50K	3.5%	Form 4
Aug 22, 2025	Thomas Carlton Stewart See Remarks	SoldNo plan	5,768	$1.74	10K	7.8%	Form 4
Aug 22, 2025	Christelle Gedeon See Remarks	SoldNo plan	16,929	$1.74	29K	4.4%	Form 4
Aug 18, 2025	Christelle Gedeon See Remarks	SoldNo plan	4,528	$1.86	8K	1.2%	Form 4
Jun 30, 2025	Theresa Yanofsky Director	SoldNo plan	10,425	$1.23	13K	11%	Form 4
Jun 30, 2025	Willy Kruh Director	SoldNo plan	10,468	$1.23	13K	12%	Form 4
Jun 30, 2025	David Angelo Lazzarato Director	SoldNo plan	15,701	$1.23	19K	12%	Form 4
Jun 16, 2025	Judy Eun Joo Hong Chief Financial Officer	SoldNo plan 2 parts	38,678	$1.63 average	63K	6.3%	Form 4
Jun 16, 2025	Christelle Gedeon See Remarks	SoldNo plan	9,555	$1.47	14K	2.4%	Form 4
Mar 31, 2025	Theresa Yanofsky Director	SoldNo plan	2,004	$0.92	2K	9.0%	Form 4
Mar 31, 2025	David Angelo Lazzarato Director	SoldNo plan	3,004	$0.92	3K	12%	Form 4
Mar 31, 2025	Willy Kruh Director	SoldNo plan	2,012	$0.92	2K	18%	Form 4
Dec 31, 2024	Willy Kruh Director	SoldNo plan	2,004	$2.67	5K	15%	Form 4
Dec 31, 2024	Theresa Yanofsky Director	SoldNo plan	1,996	$2.67	5K	8.2%	Form 4
Dec 31, 2024	Luc Mongeau Director	SoldNo plan	2,004	$2.67	5K	15%	Form 4

Sep 28No plan
Theresa Yanofsky
Director · sold 14,920 at $0.93
14K
10% of stake
Sep 28No plan
David Angelo Lazzarato
Director · sold 22,380 at $0.93
21K
11% of stake
Sep 28No plan
Joseph Bayern
Director · sold 3,096 at $0.93
3K
2.1% of stake
Sep 28No plan
M Shan Atkins
Director · sold 3,096 at $0.93
3K
2.1% of stake
Sep 17No plan
Thomas Carlton Stewart
See Remarks · sold 25,755 at $0.93
24K
4.2% of stake
Aug 24No plan
Christelle Gedeon
See Remarks · sold 13,344 at $1.47
20K
1.9% of stake
Aug 24No plan
Thomas Carlton Stewart
See Remarks · sold 2,231 at $1.47
3K
0.4% of stake
Jun 26No plan
Joseph Bayern
Director · sold 3,197 at $0.92
3K
2.2% of stake
Jun 26No plan
Theresa Yanofsky
Director · sold 15,054 at $0.92
14K
9.3% of stake
Jun 26No plan
M Shan Atkins
Director · sold 3,197 at $0.92
3K
2.1% of stake
Jun 26No plan
David Angelo Lazzarato
Director · sold 22,674 at $0.92
21K
9.7% of stake
Jun 17No plan
Thomas Carlton Stewart
See Remarks · sold 9,285 at $0.97
9K
1.5% of stake
Jun 17No plan
Christelle Gedeon
See Remarks · sold 58,994 at $0.97
57K
7.7% of stake
Jun 17No plan
Luc Mongeau
Chief Executive Officer · sold 135,231 at $0.97
131K
7.3% of stake
Mar 31No plan
Theresa Yanofsky
Director · sold 10,373 at $0.93
10K
16% of stake
Mar 31No plan
M Shan Atkins
Director · sold 2,074 at $0.93
2K
4.8% of stake
Mar 31No plan
Joseph Bayern
Director · sold 2,658 at $0.93
2K
6.2% of stake
Mar 31No plan
David Angelo Lazzarato
Director · sold 15,624 at $0.93
15K
18% of stake
Feb 11No plan
Luc Mongeau
Chief Executive Officer · sold 9,376 at $1.06
10K
1.2% of stake
Dec 31, 2025No plan
Theresa Yanofsky
Director · sold 10,434 at $1.13
12K
14% of stake
Dec 31, 2025No plan
David Angelo Lazzarato
Director · sold 15,715 at $1.13
18K
15% of stake
Sep 29, 2025No plan
David Angelo Lazzarato
Director · sold 15,677 at $1.58
25K
13% of stake
Sep 29, 2025No plan
M Shan Atkins
Director · sold 2,216 at $1.58
4K
4.9% of stake
Sep 29, 2025No plan
Theresa Yanofsky
Director · sold 10,408 at $1.58
16K
12% of stake
Sep 29, 2025No plan
Willy Kruh
Director · sold 10,451 at $1.58
17K
14% of stake
Sep 22, 2025
Luc Mongeau
Chief Executive Officer · bought 27,469 at $1.82
50K
3.5% of stake
Aug 22, 2025No plan
Thomas Carlton Stewart
See Remarks · sold 5,768 at $1.74
10K
7.8% of stake
Aug 22, 2025No plan
Christelle Gedeon
See Remarks · sold 16,929 at $1.74
29K
4.4% of stake
Aug 18, 2025No plan
Christelle Gedeon
See Remarks · sold 4,528 at $1.86
8K
1.2% of stake
Jun 30, 2025No plan
Theresa Yanofsky
Director · sold 10,425 at $1.23
13K
11% of stake
Jun 30, 2025No plan
Willy Kruh
Director · sold 10,468 at $1.23
13K
12% of stake
Jun 30, 2025No plan
David Angelo Lazzarato
Director · sold 15,701 at $1.23
19K
12% of stake
Jun 16, 2025No plan
Judy Eun Joo Hong
Chief Financial Officer · sold 38,678 at avg $1.63
63K
6.3% of stake
Jun 16, 2025No plan
Christelle Gedeon
See Remarks · sold 9,555 at $1.47
14K
2.4% of stake
Mar 31, 2025No plan
Theresa Yanofsky
Director · sold 2,004 at $0.92
2K
9.0% of stake
Mar 31, 2025No plan
David Angelo Lazzarato
Director · sold 3,004 at $0.92
3K
12% of stake
Mar 31, 2025No plan
Willy Kruh
Director · sold 2,012 at $0.92
2K
18% of stake
Dec 31, 2024No plan
Willy Kruh
Director · sold 2,004 at $2.67
5K
15% of stake
Dec 31, 2024No plan
Theresa Yanofsky
Director · sold 1,996 at $2.67
5K
8.2% of stake
Dec 31, 2024No plan
Luc Mongeau
Director · sold 2,004 at $2.67
5K
15% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CGC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with CGC

CompareIntrinsic value

JUSHFJushi Holdings Inc.

C$0.66-8.33%39

BTMDBiote Corp.

$1.23+9.38%53

CRONCronos Group Inc.

$3.51+3.85%81

MRMDMariMed Inc.

$0.06+25.83%35

NAIINatural Alternatives International Inc.

$1.10+3.77%3

NAGENiagen Bioscience Inc.

$2.52+6.78%61

MTEXMannatech, Incorporated

$8.64-0.12%52

FTLFFitLife Brands, Inc.

$8.18+3.68%80

Held by ETFs

CGC is in 3 US ETFs. The largest of them, with CGC's weight in each:

Spot a number that looks wrong? Check it in CGC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CGC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.